Boehringer Ingelheim's expenditure on research and development 2004-2023
In 2023, the company invested 5.8 billion euros in research and development. The Boehringer Ingelheim group is one of the world's top 20 pharmaceutical companies. The company is headquartered in Ingelheim, Germany. This statistic describes the expenditure on research and development by pharmaceutical company Boehringer Ingelheim from 2004 to 2023.